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Programmed necrosis is a form of caspase-indepen-
dent cell death whose molecular regulation is poorly
understood. The kinase RIP1 is crucial for pro-
grammed necrosis, but also mediates activation of
the prosurvival transcription factor NF-kB.We postu-
lated that additional molecules are required to
specifically activate programmed necrosis. Using
a RNA interference screen, we identified the kinase
RIP3 as a crucial activator for programmed necrosis
induced by TNF andduring virus infection. RIP3 regu-
lates necrosis-specific RIP1 phosphorylation. The
phosphorylation of RIP1 and RIP3 stabilizes their
associationwithin thepronecrotic complex, activates
the pronecrotic kinase activity, and triggers down-
stream reactive oxygen species production. The
pronecrotic RIP1-RIP3 complex is induced during
vaccinia virus infection. Consequently, RIP3/mice
exhibited severely impaired virus-induced tissue
necrosis, inflammation, and control of viral replica-
tion. Our findings suggest that RIP3 controls pro-
grammed necrosis by initiating the pronecrotic
kinase cascade, and that this is necessary for the
inflammatory response against virus infections.
INTRODUCTION
Cell death by programmed necrosis (also known as caspase-
independent cell death or necroptosis) is characterized by rapid
loss of plasma membrane integrity prior to the exposure of
phagocytic signal (Golstein and Kroemer, 2007). The release of
endogenous ‘‘danger signals’’ from necrotic cells induces inflam-
mation and can activate immune responses, trigger inflammatory
diseases, and promote cancer growth (Kono and Rock, 2008).1112 Cell 137, 1112–1123, June 12, 2009 ª2009 Elsevier Inc.In addition, nonapoptotic or necrotic cell death has been shown
to critically regulate disease pathologies in animal models of
hypoxic/ischemic injury (Degterev et al., 2005), acute pancreatitis
(Mareninova et al., 2006), and septic shock (Cauwels et al.,
2003). Consistent with these observations, blockade of necrosis
was effective in slowing or reducing cell injury in models of
cardiac infarct (Smith et al., 2007) and ischemic brain injury (Deg-
terev et al., 2005). Despite its biological importance, the molec-
ular components regulating programmed necrosis are not well
defined.
Tumor necrosis factor (TNF)-like cytokines are potent inducers
of programmed necrosis. We and others have previously identi-
fied an obligate role for the protein serine/threonine kinase
receptor interacting protein 1 (RIP/RIP1/RIPK1) in programmed
necrosis (Chan et al., 2003; Holler et al., 2000; Lin et al., 2004).
RIP1 is also a crucial adaptor that mediates activation of the
prosurvival transcription factor NF-kB by TNF, TLR3, and TLR4
(Cusson-Hermance et al., 2005; Hsu et al., 1996; Meylan et al.,
2004; Ting et al., 1996). The kinase function of RIP1 is essential
for programmed necrosis but dispensable for NF-kB activation
(Chan et al., 2003; Holler et al., 2000; Lin et al., 2004), suggesting
that programmed necrosis might be regulated at the level of
activation of RIP1 kinase activity. However, the molecular mech-
anism that activates the pronecrotic RIP1 kinase activity has
remained elusive.
Necrosis distinguishes itself from apoptosis by its proinflam-
matory effects. The release of endogenous adjuvants from
necrotic cells can activate the inflammasomes, induce cytokine
production, facilitate inflammatory cell recruitment to the site of
infection, stimulate dendritic cell maturation, and promote the
subsequent virus-specific T cell responses (Kono and Rock,
2008). These proinflammatory effects of necrosis are important
for successful antiviral immune responses. In addition, pro-
grammed necrosis may control the viral factory by eliminating
the infected host cells. An antiviral role for programmed necrosis
is further bolstered by our previous findings that certain viral
FLIPs (FLICE-like inhibitor proteins) are potent inhibitors of
TNF-induced programmed necrosis (Chan et al., 2003). These
results suggest that viral inhibition of programmed necrosis is
an important immune evasion strategy for certain viruses. How-
ever, because genetic ablation of the only known programmed
necrosis mediator RIP1 resulted in neonatal lethality (Kelliher
et al., 1998), the physiological roles of programmed necrosis in
inflammation and antiviral host defense have not been tested.
In this report, we identify RIP3 as a crucial upstream activating
kinase that regulates RIP1-dependent programmed necrosis.
We show that RIP3 acts upstream to phosphorylate RIP1. Inter-
estingly, the RIP1 kinase activity is also required for necrosis-
specific RIP3 phosphorylation. Both RIP3 and the kinase activity
of RIP1 are essential for stable formation of the RIP1-RIP3 pro-
necrotic complex, which critically controls downstream reactive
oxygen species (ROS) production. Strikingly, the pronecrotic
RIP1-RIP3 complex was specifically induced in the liver upon
vaccinia virus (VV) infection. RIP3/ mice failed to initiate
virus-induced tissue necrosis and inflammation, resulting in
highly elevated viral replication and mortality. These results
show that RIP3-dependent programmed necrosis is important
for virus-induced inflammation and innate immune control of
viral infections.
RESULTS
Identification of RIP3 as a Mediator for Programmed
Necrosis
RIP1 is a pleiotropic adaptor that mediates both NF-kB activa-
tion and programmed necrosis by TNF (Chan et al., 2003; Holler
et al., 2000; Lin et al., 2004). The kinase activity of RIP1 is essen-
tial for programmed necrosis, but dispensable for NF-kB activa-
tion (Chan et al., 2003; Holler et al., 2000). We hypothesized
that induction of programmed necrosis requires additional
components that specifically turn on the RIP1 kinase activity.
To identify such molecules, we screened a 21-mer small inter-
fering RNA (siRNA) library consisting of 691 human kinase genes
in FADD-deficient Jurkat cells (Table S1 available online, and the
Supplemental Experimental Procedures), which rapidly undergo
programmed necrosis in response to TNF (Chan et al., 2003).
From the screen, we identified ten clones that potently inhibited
TNF-induced programmed necrosis (% survival > average
survival of all clones + 3 SD) (Table S2). Significantly, RIP1 was
one of the protective clones, demonstrating the fidelity of our
screen. Transfection of siRNA against RIP3 also conferred
protection against TNF-induced programmed necrosis at a level
comparable to that by RIP1 siRNA (Figure S1). The protection
against TNF-induced programmed necrosis by RIP1 and RIP3
siRNAs were specific, since other RIP family kinases including
rip2, rip4, and rip5 that were represented in the library did not
protect against programmed necrosis (data not shown). We vali-
dated these results in TNFR-2+ wild-type Jurkat cells (clone 4E3)
and found that individual RIP3-specific siRNAs efficiently
reduced RIP3 protein expression (Figure 1A) and inhibited TNF/
zVAD-fmk-induced programmed necrosis (Figure 1B), but had
little or no effects on apoptosis induced by TNF or FasL
(Figure 1C-D). Consistent with a previous report (Newton et al.,
2004), RIP3 deficiency did not alter TNF-induced NF-kB activa-
tion (Figure 1E). Thus, unlike RIP1, RIP3 is a specific activator for
programmed necrotic cell death.The Kinase and RHIM Domains of RIP3 Are Required
to Induce Programmed Necrosis
RIP3 contains an N-terminal kinase domain with 40% identity
with the kinase domain of RIP1 (Figure 2A). A kinase-defective
(KD) RIP3 mutant failed to restore TNF-induced programmed
necrosis in Jurkat cells whose endogenous RIP3 expression
was silenced by siRNA (Figure 2B, RIP3 null Jurkat cells), indi-
cating that the RIP3 kinase activity is crucial for programmed
necrosis. RIP1 and RIP3 have been reported to interact with
each other via the RIP homotypic interaction motif (RHIM)
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Figure 1. RIP3 Is Specifically Required for Programmed Necrosis,
but Not Apoptosis or NF-kB Induction
Wild-type TNFR2+ Jurkat cells were transfected with siRNAs against RIP1,
RIP3 or control siRNA against TRAIL-R4 (TR4).
(A) Western blot of RIP1, RIP3 and b-actin expression in cells transfected with
the indicated siRNAs.
(B–D) Cells were tested for TNF/zVAD-fmk-induced programmed necrosis
(*p = 0.005, **p < 0.001) (B), TNF-induced apoptosis (C), or FasL-induced
apoptosis 48 hr post-transfection (D). Data are presented as mean ± SEM of
triplicates.
(E) Wild-type and RIP3/ MEFs were treated with TNF for the indicated times
and IkBa degradation was analyzed by Western blot.Cell 137, 1112–1123, June 12, 2009 ª2009 Elsevier Inc. 1113
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Figure 2. Requirement of Kinase and RHIM Domains of RIP3 for Programmed Necrosis
(A) Domain structures of RIP1 and RIP3.
(B and C) The RIP3 kinase and RHIM domains are required for programmed necrosis. Wild-type TNFR2+ Jurkat cells were transfected with siRNA against human
RIP3. After 24 hr, cells were transfected with the indicated GFP-tagged plasmids: kinase-dead (KD, D161N) mouse RIP3 (B) and RIP3 RHIM mutant (C). TNF/
zVAD-induced programmed necrosis was determined in the transfected GFP+ population.
(D) The kinase and RHIM domains of RIP1 are required for programmed necrosis. RIP1-deficient Jurkat cells were transfected with the indicated GFP-tagged
RIP1 plasmids. TNF/zVAD-fmk induced programmed necrosis was determined as in (B) and (C). Data are presented as mean ± SEM of triplicates.
(E) RIP3 is recruited to complex II. Complex II was isolated with caspase-8 specific antibody from wild-type TNFR2+ Jurkat cells stimulated with TNF ± zVAD-fmk,
and the recruitment of RIP1 and RIP3 was determined by western blot. WCE, whole-cell extract; C8, caspase-8.
(F) RIP3 is not recruited to the TNFR-1 signaling complex. TNFR-1 immune complexes from TNFR2+ Jurkat cells stimulated with TNF ± zVAD-fmk for the indicated
times were examined for the recruitment of RIP1 and RIP3 by western blot. RIP1-Ub, polyubiquitinated RIP1.(Figure 2A) (Sun et al., 2002). Tetra-alanine substitutions in the
RHIM of RIP1 or RIP3 abolished their association (Figure S2)
and the ability of RIP3 to restore TNF-induced programmed
necrosis in RIP3 null Jurkat cells (Figure 2C). Similar mutations
in the kinase and RHIM domains of RIP1 also abolished the
RIP1-mediated rescue of programmed necrosis in RIP1-defi-
cient Jurkat cells (Figure 2D). Thus, both the kinase and RHIM
domains of RIP1 and RIP3 are important for programmed
necrosis.
RIP3 Is Recruited to Complex II during Programmed
Necrosis
TNFR signaling involves at least two spatially and temporally
distinct signaling complexes: the transient membrane-associ-
ated TNFR-1 signaling complex (complex I) and the cytoplasmic
signaling complex termed complex II (Micheau and Tschopp,
2003). Complex II is formed upon TNFR-1 internalization, when
TNFR-1 dissociates from complex I to allow recruitment of addi-
tional factors. Because RIP1 is recruited to both complex I and
complex II, we examined RIP3 recruitment to these signaling
complexes. In TNFR-2+ Jurkat 4E3 cells, TNF triggers both
apoptosis and programmed necrosis, although apoptosis
predominates because of its faster kinetics unless caspases
are inhibited (Zheng et al., 2006). In TNFR-2+ Jurkat 4E3 cells,1114 Cell 137, 1112–1123, June 12, 2009 ª2009 Elsevier Inc.RIP3 was recruited to caspase-8-associated complex II
(Figure 2E), but not to TNFR-1 associated complex I (Figure 2F).
On short exposure, zVAD-fmk moderately enhanced RIP1 and
RIP3 binding to caspase-8-associated complex II (Figure 2E).
However, the difference was minor and not distinguishable on
longer exposure (Figure S3). On longer exposure, RIP1 cleavage
in complex II was also visible (Figure S3). Although RIP1 cleavage
by caspase-8 at D324 might inactivate the RIP1 kinase function
and contribute to the bifurcation of apoptosis and programmed
necrosis (Lin et al., 1999), zVAD-fmk probably sensitizes cells
to programmed necrosis via additional regulatory events
because full-length RIP1 was still readily detected without cas-
pase inhibition (Figure S3).
Induction of Pronecrotic Complex II Kinase Activity
The recruitment of RIP1 and RIP3 to complex II suggests that
their pronecrotic kinase activity might be activated within this
complex. When caspase-8-associated complex II was exam-
ined, we did not observe strong TNF-inducible kinase activity
(data not shown). Hence, although RIP1 and RIP3 were recruited
to caspase-8, their activities were not regulated in this compart-
ment. In contrast, complex II isolated by immunoprecipitation
with FADD-specific antibody exhibited a transient induction of
kinase activity as measured by phosphorylation of an 60 kDa
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Figure 3. The RIP1-Dependent Pronecrotic Kinase Activity Was Induced in Complex II
(A) TNFR2+ Jurkat cells were treated with TNF ± zVAD-fmk for the indicated times. Complex II was isolated by FADD immunoprecipitations and subjected to
in vitro kinase assays with [32P]-gATP. The fold induction of kinase activity was quantified by densitometry of the 60 kDa band indicated by the arrow. Lower
panels show the western blot analyses of the isolated FADD complexes.
(B) Induction of complex II kinase activity can be measured using MBP as artificial substrate. FADD complexes from caspase-8-deficient Jurkat cells were sub-
jected to in vitro kinase assay using [32P] g-ATP and MBP as substrate. The arrows indicate the phosphorylated MBP and complex II components. Lower panels
show the western blot analyses of the isolated complex II.
(C) Complex I did not exhibit TNF-dependent induction of kinase activity. IP kinase assays were performed with the isolated TNFR-1 complexes in the presence of
[32P]-gATP (top). Lower panels show the western blot analyses of complex I.
(D) Complex II kinase activity was not detected in cells that do not undergo programmed necrosis. TNFR2- Jurkat cells were treated with TNF for the indicated
times. The isolated FADD complexes were subjected to in vitro kinase assays as in (A).
(E) RIP1 is required for induction of complex II kinase activity. RIP1-deficient Jurkat cells were treated with TNF, and the isolated FADD complexes were tested in
in vitro kinase assays as in (A).protein and several other species (Figure 3A, top panel). We
confirmed the identity of the 60 kDa phospho-protein to be
RIP3 when we boiled the TNF-activated FADD complex in SDS
and subjected it to a second immunoprecipitation with RIP3-
specific antibody (Figure 3B, lane 5). In addition to RIP3, complex
II kinase activity could also be measured with the artificial
substrate MBP (Figure 3B, lane 3). Similar complex II kinase
activity could also be detected in caspase-8-deficient Jurkat
cells undergoing programmed necrosis (Figure S4). Interestingly,
FADD complex kinase activity was detected in TNF-treated
TNFR2+ Jurkat cells when apoptosis was the dominant cell death
mode (Figure 3A, lane 2). Although zVAD-fmk slightly increased
complex II kinase activity (Figure 3A, lane 5), these results
suggest that zVAD-fmk might exert its necrosis-promoting
effects subsequent to the induction of complex II kinase activity.
Consistent with the lack of RIP3 binding to complex I, TNF did
not activate kinase activity in TNFR-1 complexes (Figure 3C).
Moreover, TNFR-2 Jurkat cells that did not undergo pro-
grammed necrosis in response to TNF (Chan and Lenardo, 2000)
also exhibited no inducible FADD complex II kinase activity
regardless of whether zVAD-fmk was present (Figure 3D). Thus,
the induction of complex II kinase activity was specific to pro-
grammed necrosis. Complex II kinase activity was also not
detected in TNFR2+ RIP1-deficient Jurkat cells, which undergo
apoptosis in response to TNF (Chan et al., 2003) (Figure 3E). In
addition, the RIP1 kinase inhibitor necrostatin-1 (Nec-1) potently
inhibited complex II kinase activity (Figure S4). Interestingly, while
RIP1 was recruited to FADD in a TNF-dependent manner, RIP3was constitutively associated with FADD (Figure 3A, lower
panels), although this interaction may be indirect (Figure S4).
Taken together, our results show that RIP1 recruitment to
complex II is crucial for the induction of pronecrotic complex II
kinase activity.
RIP3 Controls RIP1 Binding to Complex II
Although the induction of complex II kinase activity appears to
correlate with programmed necrosis, it could not be explained
entirely by RIP1 recruitment to complex II because RIP1 was
recruited to complex II in cells that did not undergo necrotic death
(Figure 3D, lower panels). To further define the molecular regula-
tion of programmed necrosis, we examined the recruitment of
RIP1 and RIP3 to complex II in mouse embryonic fibroblasts
(MEFs) because the role of RIP3 in the assembly of the prone-
crotic complex could be evaluated with RIP3/ MEFs. Similar
to Jurkat cells, constitutive association between RIP3 and
FADD was also detected in MEFs (Figure 4A). When programmed
necrosis was induced in wild-type MEFs with TNF, cycloheximide
and zVAD-fmk (T/C/Z) (Figure S5), RIP1 was recruited to FADD in
a TNF-dependent manner (Figure 4A, lane 3). Moreover, TNF
treatment led to further recruitment of RIP3 to the FADD-associ-
ated complex II and RIP3 modification that resembles polyubi-
quitination (Figure 4A, lane 3). Preliminary evidence suggests
that these modifications were indeed polyubiquitination (F.K.C.,
unpublished data). Strikingly, RIP1 recruitment to complex II
was severely impaired in RIP3/ MEFs (Figure 4A, lanes 5–8).
The RIP1 kinase inhibitor Nec-1 (Degterev et al., 2008) alsoCell 137, 1112–1123, June 12, 2009 ª2009 Elsevier Inc. 1115
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Figure 4. Phosphorylation of RIP1 and RIP3 Critically Regulates Formation of the Pronecrotic RIP1-RIP3 Complex
(A) RIP3 is essential for RIP1 recruitment to FADD-associated complex II. FADD was immunoprecipitated from RIP3+/+ and RIP3/ MEFs after treatment with
TNF, cycloheximide, and zVAD-fmk for the indicated times. In lanes 4 and 8, cells were also treated with Nec-1.
(B) RIP3 is required for necrosis-specific RIP1 phosphorylation. RIP3+/+ (lanes 1–4) and RIP3/ (lanes 5 and 6) MEFs were labeled with [32P]-orthophosphate and
treated with TNF alone or TNF in the presence of cycloheximide and zVAD-fmk (C/Z) for 6 hr. RIP1 was immunoprecipitated and assessed for phosphorylation
by autoradiography. Bottom panels show that equal amounts of RIP1 were present.
(C) Necrosis-dependent RIP1 phosphorylation was not mediated by RIP1 autophosphorylation. FADD-deficient Jurkat cells were labeled with [32P]-orthophos-
phate and treated with TNF for 2 hr. In lane 3, cells were pretreated with Nec-1. The bottom panels show that equal amounts of RIP1 were pulled down.
(D) RIP1 is a kinase substrate for RIP3. The indicated GFP-tagged wild-type (WT) or kinase-defective (KD) RIP1 or RIP3 were expressed in 293T cells, immuno-
precipiated with anti-GFP antibody, and subjected to in vitro kinase assay with [32P] g-ATP. MBP was also included as artificial substrate. Top panel: autoradio-
graph. Bottom panel: western blot analysis with anti-GFP antibody. IgGL, immunoglobulin light chain. The fold-increase in RIP1 phosphorylation was determined
by densitometry and by normalizing the amount of RIP1 phosphorylation to the expression level of RIP1 and/or RIP3. For comparison, the background signal in
lane 8 was set as 1.
(E) Specific association of RIP1 and RIP3 during programmed necrosis. Wild-type MEFs were treated with TNF in the presence of cycloheximide (T/C) to induce
apoptosis or cycloheximide and zVAD-fmk (T/C/Z) to induce programmed necrosis. Recruitment of RIP3 to RIP1 was examined by western blot.
(F and G) The kinase activity of RIP1 is required for formation of the pronecrotic RIP1-RIP3 complex.
(F) Wild-type MEFs were treated as in (E), except that in lanes 4 and 8, cells were pretreated with of Nec-1.
(G) Wild-type MEFs were treated with T/C/Z for 6 hr. In lane 3, cells were pretreated with Nec-1. RIP3 was immunoprecipitated, and the association with RIP1 was
examined by western blot.
(H) RIP1 kinase activity is required for necrosis-specific RIP3 phosphorylation. Wild-type MEFs were labeled with [32P]-orthophosphate and RIP3 was immuno-
precipitated with specific antibody after 6 hr of treatment with TNF or T/C/Z. Top panel: autoradiograph. Bottom panel: RIP3 western blot.abolished RIP1 recruitment to FADD and inhibited additional
RIP3 binding to the complex (Figure 4A, lane 4, and Figure S6).
These results indicate that both RIP1 and RIP3 are critical for
the assembly of the pronecrotic complex II.
RIP3 Acts Upstream to Regulate RIP1 Phosphorylation
We then ascertained the possibility that RIP3 might regulate
RIP1 recruitment to the pronecrotic complex II via phosphoryla-
tion by labeling of MEFs with [32P]-orthophosphate. Indeed, RIP1
phosphorylation was detected when programmed necrosis was
induced (Figure 4B, lane 2). Although low levels of basal RIP1
phosphorylation could sometimes be detected, TNF treatment
alone, which did not result in apoptosis or programmed necrosis
(Figure S6), did not induce RIP1 phosphorylation (Figure 4B,
lanes 3 and 4). Strikingly, ligand-dependent RIP1 phosphoryla-
tion was completely abrogated in RIP3/ MEFs (Figure 4B,1116 Cell 137, 1112–1123, June 12, 2009 ª2009 Elsevier Inc.lanes 5 and 6). Similar TNF-dependent RIP1 phosphorylation
was observed in FADD-deficient Jurkat cells (Figure 4C, lane 2).
Importantly, Nec-1 did not inhibit RIP1 phosphorylation (Fig-
ure 4C, compare lanes 2 and 3), indicating that TNF-dependent
RIP1 phosphorylation was not due to autophosphorylation. To
determine whether RIP1 might directly phosphorylate RIP3, we
subjected wild-type or kinase-defective RIP1 and/or RIP3
expressed in 293T cells to in vitro kinase assays. Indeed, WT-
RIP3 phosphorylated KD-RIP1 to a level comparable to that
achieved via RIP1 autophoshorylation (Figure 4D, compare lanes
6 and 7). In contrast, although WT-RIP1 could undergo auto-
phosphorylation, it did not phosphorylate KD-RIP3 (Figure 4D,
lane 6). However, the level of RIP3-mediated RIP1 phosphoryla-
tion was weak, suggesting that other kinases might be involved
in phosphorylating RIP1 and stabilizing its association with the
pronecrotic complex II.
F G
D EA B
C
Figure 5. RIP3 Regulates Downstream ROS Production
(A–C) RIP3 is required for downstream ROS production during programmed necrosis.
(A) RIP3+/+ and RIP3/ MEFs were treated with TNF and cycloheximide (T/C) or T/C and zVAD-fmk (T/C/Z) for 6 hr. ROS production was quantified using the
fluorescent dye H2DCFDA on flow cytometry. Data are presented as mean ± SEM of triplicates.
(B) Cell death was quantified using propidium iodide uptake. Data are presented as mean ± SEM of triplicates.
(C) Flow cytometric analysis of RIP3-dependent ROS production during programmed necrosis. The numbers represent the percentages of cells in each quandrant.
(D and E) RIP3 is not required for oxidative stress-induced cell injury.
(D) L929 cells transfected with the indicated siRNAs were treated with 0.2 mM H2O2. Cell death was assessed by MTS assay 6 hr later. Data are presented as
mean ± SEM of triplicates.
(E) Dose-dependent response of L929 cells transfected with the RIP3 siRNA to H2O2-induced cell death. Cell death was measured by MTS assay 6 hr after stim-
ulation. Data are presented as mean ± SEM of triplicates.
(F and G) RIP3 is required for zVAD-fmk-induced, autocrine TNF-dependent necrosis.
(F) L929 cells transfected with the indicated siRNAs were treated with 50mM of zVAD-fmk, and cell death was determined by MTS assay 24 hr later. The inset shows
the reduction of RIP1 or RIP3 protein expression by the respective siRNAs. Data are presented as mean ± SEM of triplicates. *p = 0.01, **p = 0.002, ***p < 0.001.
(G) Dose-dependent response to zVAD-fmk induced necrosis of L929 cells transfected with the RIP3 siRNA. Cell death was measured by MTS assay 24 hr later.
Data are presented as mean ± SEM of triplicates. *p = 0.027, **p = 0.018, ***p = 0.001.The Kinase Activity of RIP1 Is Required for Stable
Assembly of the Pronecrotic Complex II
Recent evidence indicates that signal transduction by TNFR-like
receptors may involve distinct complex IIs (Wang et al., 2008;
Wilson et al., 2009). We reasoned that RIP1 and RIP3 might
interact specifically within a pronecrotic complex II. In MEFs,
TNF stimulation in the presence of cycloheximide induces
apoptosis (T/C), but not programmed necrosis (Lin et al., 2004)
(Figure S6). Under these conditions, no interaction between
RIP1 and RIP3 was detected (Figure 4E, lanes 1–4). By contrast,
programmed necrosis induced by T/C/Z specifically induced
formation of the RIP1-RIP3 complex (Figure 4E, lanes 5–8).
Similar to the recruitment of RIP1 and RIP3 to FADD, the interac-
tion between RIP1 and RIP3 was abolished by Nec-1 (Figure 4F,
compare lanes 7 and 8, and Figure 4G, lanes 2 and 3), indicating
that the RIP1 kinase activity was also required for stable interac-
tion between RIP1 and RIP3. The effect of Nec-1 on RIP1-RIP3
association might be due to inhibition of RIP3 phosphorylation,since necrosis-specific RIP3 phosphorylation was abolished by
Nec-1 (Figure 4H, compare lanes 2 and 3). Because RIP1 did
not directly phosphorylate RIP3 (Figure 4D), another down-
stream kinase might be responsible for RIP3 phosphorylation.
Taken together, our data strongly implicate that phosphoryla-
tion of RIP1 and RIP3 plays a crucial role in the stable assembly
of the pronecrotic complex II.
RIP3 Regulates Downstream ROS Production during
Programmed Necrosis
A recent report shows that the NADPH oxidase Nox1 acts within
the membrane-associated receptor complex to generate super-
oxide anions during programmed necrosis (Kim et al., 2007).
Since RIP3 acts within the cytoplasmic signaling complex, we
asked whether RIP3 might function downstream of ROS to
promote programmed necrosis. Surprisingly, ROS production
as detected by staining with 20,70-dichlorodihydrofluorescein
diacetate (H2DCFDA) (Figure 5A), and necrotic cell death asCell 137, 1112–1123, June 12, 2009 ª2009 Elsevier Inc. 1117
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Figure 6. RIP3 Regulates Cell Death during Virus Infections
(A and B) RIP3 is essential for AICD- and TNF-induced death in VV-infected T cells. Wild-type (white bars) or RIP3/ (black bars) T cells were infected with GFP-
VV (moi = 10) and stimulated with plate-bound anti-CD3 antibody (A) or mTNF (B). Cell death in the GFP+ infected population and the GFP uninfected population
was determined by PI staining and flow cytometry. Data are presented as mean ± SEM of triplicates.
(C) RIP3 is required for T cell AICD when caspases are inhibited. Wild-type or RIP3/ T cells were stimulated with different doses of plate-bound anti-CD3 anti-
body in the presence or absence of zVAD-fmk. Cell death was assessed by PI uptake on flow cytometry. Data are presented as mean ± SEM of triplicates.
(D) VV infection sensitizes MEFs to TNF-induced programmed necrosis in a RIP3-dependent manner. RIP3+/+ and RIP3/ MEFs were infected with GFP-VV
(moi = 0.5). Infected cells were treated with TNF, and cell death was determined by PI uptake in the infected GFP+ populations by flow cytometry. Data are pre-
sented as mean ± SEM of triplicates.
(E) Electron microscopy shows that VV-infected MEFs underwent necrosis in response to TNF. Panel a: uninfected cell. Panel b: VV-infected cell (no TNF). The
electron-dense structures indicated by the arrows are viral particles. Panel c: VV-infected cell treated with TNF. Scale bars represent 2 mm.
(F) Formation of the pronecrotic RIP1-RIP3 complex in VV-infected MEFs. Uninfected MEFs (lanes 1–4) or VV-infected MEFs (lanes 5–8) were treated with TNF ±
zVAD-fmk as indicated. RIP1 was immunoprecipitated, and the presence of RIP3 in the immune complex was determined by western blot.detected by propidium iodide (PI) uptake were completely
inhibited in RIP3/ MEFs (Figures 5B and 5C). Similar results
were obtained with the murine fibrosarcoma L929 transfected
with RIP3-specific siRNA (Figure S7). Unlike programmed
necrosis, silencing of RIP1 or RIP3 expression in L929 cells
had no effect on hydrogen peroxide-induced oxidative cell injury
(Figures 5D and 5E). By contrast, siRNA-mediated silencing of
RIP1 or RIP3 inhibited zVAD-fmk-induced necrosis in L929 cells
(Figures 5F and 5G), which was recently shown to be driven by
autocrine TNF production (Hitomi et al., 2008). Thus, our results
indicate that RIP3 acts upstream to regulate ROS production
during programmed necrosis.
RIP3-Dependent Programmed Necrosis Is an Important
Cell Death Mechanism during Vaccinia Virus Infection
One physiological situation in which caspases are inhibited and
programmed necrosis might be important is during viral infec-
tions (Benedict et al., 2002). To test this hypothesis, we examined
cell death responses in activated wild-type and RIP3/ T cells
infected with vaccinia virus (VV), which encodes the viral caspase1118 Cell 137, 1112–1123, June 12, 2009 ª2009 Elsevier Inc.inhibitor B13R/Spi2. VV-infected cells were resistant to death
receptor-induced apoptosis but become sensitized to TNF-
induced necrosis (Li and Beg, 2000). Wild-type T cells infected
with recombinant GFP-VV exhibited normal T cell activation-
induced cell death (AICD) induced by anti-CD3 antibody
(Figure 6A, compare the white bars). In contrast, AICD in GFP-
VV-infected RIP3/ T cells was significantly reduced compared
with uninfected GFP cells in the same culture (Figure 6A,
compare the black bars). VV-infected RIP3/ cells were also
protected from TNF-induced cell death (Figure 6B, black bars).
In fact, TNF stimulated the proliferation of GFP+ VV-infected
RIP3/ cells, which accounted for the negative cell loss. VV-
infected wild-type T cells also exhibited a modest decrease in
TNF-induced cell death because of the inhibition of caspase-
dependent apoptosis (Figure 6B, white bars).
The effect of VV infection on T cell death was recapitulated with
zVAD-fmk. While AICD was only moderately impaired by zVAD-
fmk in wild-type T cells, it was significantly reduced in RIP3/
cells (Figure 6C). Geldanamycin (GA), which was thought
to inhibit programmed necrosis by destabilizing RIP1 (Lewis
et al., 2000), also suppressed RIP3 protein expression
(Figure S8). Hence, GA and Nec-1 also synergized with zVAD-
fmk to suppress T cell death (Figure S8). The sensitization to pro-
grammed necrosis by VV infection was also observed in MEFs.
While TNF alone did not cause cell death in MEFs (Figure S6),
VV-infected MEFs were highly sensitive to TNF-induced necrosis
in a RIP3-dependent manner (Figure 6D). Electron microscopy
confirmed that VV-infected MEFs underwent necrotic-like cell
death in response to TNF (Figure 6E, panel c). Importantly, while
RIP1-RIP3 complex was only detected when cells were stimu-
lated with T/C/Z (Figures 4E–4G) or TNF/zVAD (Figure 6F, lanes
3 and 4), TNF alone was sufficient to trigger RIP1-RIP3 associa-
tion in VV-infected MEFs (Figure 6F, lanes 5–8). This is in stark
contrast to uninfected cells, in which TNF did not trigger RIP1
and RIP3 interaction (Figure 6F, lanes 1 and 2). Taken together,
these results show that RIP3-dependent programmed necrosis
is an important cell death mechanism when the cellular apo-
ptosis machinery was inhibited by viral inhibitors.
RIP3 Is Required for Protection against Vaccinia Virus
Infection In Vivo
TNF-TNFR interactions are known to be important for the innate
immune defense against VV infection (Chan et al., 2003; Ruby
et al., 1997). The requirement for RIP3 to induce cell death in
VV-infected cells suggests that TNF might confer protection
against VV via RIP3-dependent programmed necrosis. To test
this hypothesis, we infected wild-type and RIP3/ mice with
VV. Consistent with its innate immune protective role, TNF
expression was detected in peritoneal exudate cells (PECs) 24
hr after infection (Figure 7A). Moreover, TNF expression was
induced in the liver and spleen of infected wild-type and RIP3/
mice (Figure 7B). Thus, virus-induced TNF expression was not
impaired in the RIP3/ mice.
In wild-type mice, VV infection causes inflammation marked
by neutrophil/macrophage infiltration in the visceral fat pads
(Figure 7C, panel a, red arrows), which was conspicuously
absent in the RIP3/ mice (Figure 7C, panels c and d). Interest-
ingly, the inflammatory foci were concentrated in areas of exten-
sive fat cell necrosis in the wild-type mice (Figure 7C, panels
a and b), suggesting that necrosis might have promoted the
inflammatory reaction. The PECs might provide a source of
TNF to the visceral fat tissues (Figure 7A). In contrast, necrotic
tissue injury was significantly reduced in VV-infected RIP3/
mice (Figure 7C, panels c and d). The impairment in virus-
induced inflammation was observed on day 3 prior to the peak
of CD8+ T cell responses on days 7 and 8, consistent with defec-
tive innate immune responses in the RIP3/ mice. Similarly,
extensive inflammation and necrosis were detected in the liver
of infected RIP3+/+ mice (Figure 7D, panels a and b), but were
absent in RIP3/ and TNFR2/ mice (Figure 7D, panels
c and d). Remarkably, the pronecrotic RIP1-RIP3 complex was
detected in infected liver cell extracts 12–24 hr after infection
(Figure 7E), indicating that liver cells underwent programmed
necrosis in response to VV infection. The reduced inflammation
correlated with dramatic increases in viral titers in the visceral
fat pad (1203), liver (503), and spleen (20003) of RIP3/
mice (Figure 7F). Consequently, the RIP3/ mice succumbed
to the infection (Figure 7G). Collectively, our results stronglysupport a role for RIP3 in promoting programmed necrosis and
virus-induced inflammation (Figure S9).
DISCUSSION
RIP3 was originally identified as a NF-kB and apoptosis regulator
(Kasof et al., 2000; Pazdernik et al., 1999; Sun et al., 1999; Yu
et al., 1999). However, RIP3/ mice exhibit no remarkable
phenotypes and responded normally to apoptosis and NF-kB
activation signals (Newton et al., 2004). Thus, the biological
role of RIP3 was unknown until now. Although RIP3 was not
identified as a necrosis mediator in a recent genome-wide RNAi
screen (Hitomi et al., 2008), we show that formation of a unique
pronecrotic complex II composed of RIP1 and RIP3 is a crucial
first step in the induction of programmed necrosis. RIP3 acts
upstream to regulate necrosis-specific RIP1 phosphorylation.
However, since the level of RIP1 phosphorylation by ectopically
expressed RIP3 was low, it remains possible that RIP3 may acti-
vate another kinase that directly phosphorylates RIP1.
Interestingly, the RIP1 kinase activity is also required for RIP3
phosphorylation during programmed necrosis. Because ectopi-
cally expressed RIP1 did not phosphorylate RIP3, RIP1 may
facilitate RIP3 phosphorylation by activating another down-
stream kinase. In this regard, it is tempting to speculate that
the other kinases we identified in the siRNA screen might fulfill
this function. Alternatively, RIP1 within the pronecrotic complex
II might directly phosphorylate RIP3, since in vitro phosphoryla-
tion of RIP3 by complex II was inhibited by the RIP1-specific
inhibitor Nec-1 (Figure S4). In addition, ectopically expressed
RIP3, but not RIP3 present within the endogenous FADD
complex, efficiently phosphorylated the artificial substrate
MBP. Thus, the kinase activities of RIP1 and RIP3 are tightly
controlled within the context of the pronecrotic complex II.
Our results implicate a crucial role for RIP1 and RIP3 phosphor-
ylation in the stable assembly of the pronecrotic RIP1-RIP3
complex. Intriguingly, transfection of KD-RIP1 or KD-RIP3 did
not dominantly inhibit programmed necrosis in cells expressing
endogenous RIP1 and RIP3, but rather enhanced TNF-induced
programmed necrosis (F.K.C., unpublished data). The lack of
dominant inhibition by KD-RIP1 or KD-RIP3 might suggest oligo-
merization as a crucial first step in activating the pronecrotic
kinase complex. In such scenario, the RHIM might facilitate oligo-
merization of RIP1 and RIP3. Phosphorylation of RIP1 and RIP3
may stabilize the structural scaffold of the pronecrotic complex.
However, once the oligomer is formed, a single copy of kinase
active RIP1 and RIP3 within the oligomer might be sufficient to
activate downstream function. Consistent with this model, the
RIP3 RHIM mutant was kinase inactive and failed to sensitize
programmed necrosis in wild-type Jurkat cells (F.K.C., unpub-
lished data).
The mitochondria generate ROS as a result of oxidative
respiration. Disruption of mitochondrial function can further
exacerbate ROS release. Interestingly, several components of
the mitochondria permeability transition pore (mPTP) are kinases
substrates (Le Mellay et al., 2002; Pastorino et al., 2005). It is
therefore tempting to speculate that RIP1, RIP3, or other down-
stream kinases may phosphorylate components of the mPTP to
disrupt their functions and to trigger an increase in ROS duringCell 137, 1112–1123, June 12, 2009 ª2009 Elsevier Inc. 1119
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Figure 7. RIP3-Dependent Programmed Necrosis Is Required for Control of Vaccinia Virus Replication In Vivo
(A) Induction of TNF expression in PECs upon VV infection. PECs from uninfected or VV-infected (24 hr after infection) wild-type mice were evaluated for TNF
expression by intracellular cytokine staining and flow cytometry.
(B) Quantitative PCR analyses of TNF induction upon VV infection. Total RNA was isolated from the indicated tissues 24 hr after infection. Fold induction of TNF
mRNA was determined by comparison with uninfected controls and normalization of the TNF message to that of the 18S RNA. Data are presented as mean ±
SEM of triplicates.
(C) Visceral fat pads from VV-infected RIP3+/+ mice (panels a and b), but not RIP3/ mice (panels c and d), exhibited massive fatty tissue necrosis and inflam-
mation marked by macrophage and neutrophil infiltration. The red arrows denote the necrotic tissue mass and the inflammatory foci. Panels a and c: 43 objective.
Panels b and d: 203 objective of the boxed area in panels a and c. Images shown are representative from eight RIP3+/+ and ten RIP3/ mice.
(D) H&E staining of liver sections from RIP3+/+ (panels a and b), TNFR2/ (panel c), and RIP3/ (panel d) mice. In panels a and b, leukocyte infiltration and
necrotic cell masses (arrows) were clearly seen.
(E) Formation of the pronecrotic RIP1-RIP3 complex in VV-infected liver. Liver extracts from uninfected and VV-infected wild-type mice were harvested at
different times after infection and subjected to immunoprecipitation with RIP1 antibody. The association of RIP3 was determined by western blot.
(F) Viral titers in the visceral fat pads, livers, and spleens of RIP3+/+ and RIP3/ mice were determined on day 3 after infection.
(G) Kaplan-Meier survival plot of VV-infected RIP3+/+ and RIP3/ mice.programmed necrosis. Alternatively, the NADPH oxidase Nox-1
has been shown to mediate ROS production (Kim et al., 2007).
Although Nox-1 was implicated to signal via the TNFR-1 associ-1120 Cell 137, 1112–1123, June 12, 2009 ª2009 Elsevier Inc.ated complex, it is possible that RIP3 might also interact
with Nox-1 within the pronecrotic complex II to mediate ROS
generation.
TNF has long been known to be an important innate immune
effector cytokine against bacterial and viral infections. TNF exerts
its antimicrobial effects through induction of apoptosis and
NF-kB. Using vaccinia virus infection as a model, we have now
established RIP3-dependent programmed necrosis as a third
mechanism by which TNF contributes to innate immune control
of pathogens. TNF expression was rapidly induced upon VV infec-
tion inmultiple cell types. The expression of TNF coincided with the
formation of the pronecrotic RIP1-RIP3 complex in the liver of in-
fected mice. In RIP3/ mice, virus-induced tissue necrosis and
inflammation was severely compromised. Strikingly, the resultant
increase in viral replication was comparable to that observed in the
TNFR1/and TNFR2/mice (Chanetal., 2003;Rubyetal., 1997)
and much higher than that observed in MyD88/ or TLR2/ mice
(Zhu et al., 2007). These results are consistent with the normal TLR
responses of the RIP3/ mice (Newton et al., 2004) and indicate
that the viral disease observed in RIP3/ mice was caused by
defective TNF signaling rather than abnormal TLR signaling. Our
results also support a role for RIP3-dependent programmed
necrosis in promoting the subsequent virus-induced inflammation.
An important role for RIP1/RIP3-mediated programmed necrosis
in antiviral responses is further bolstered by our previous discovery
of certain viral FLIPs that potently inhibit programmed necrosis
(Chan et al., 2003). More recently, the M45 viral cell death inhibitor
from murine cytomegalovirus was shown to interact with RIP1 and
RIP3 via the RHIM (Upton et al., 2008). These results suggest that,
like apoptosis, inhibition of programmed necrosis might be an
emerging viral immune evasion strategy.
In addition to virus-induced inflammation, necrotic cell death
may have broader roles in regulating other inflammatory
processes through the release of ‘‘endogenous adjuvants’’ into
the tissue milieu (Kono and Rock, 2008). For example, RIP3
expression was upregulated during wound healing (Adams et al.,
2007), a biological process that shares some hallmarks of inflam-
mation. In addition, programmed necrosis can directly induce
cancer cell death or promote cancer growth and metastasis
through its proinflammatory effects (Coussens and Werb, 2002).
In this light, it is noteworthy that Non-Hodgkin’s lymphomas-asso-
ciated RIP3 SNPs have been identified (Cerhan et al., 2007). Thus,
RIP3-dependent programmed necrosis may be a significant
component in determining the outcome of viral diseases,
trauma/injury-induced inflammation, and cancers.
EXPERIMENTAL PROCEDURES
siRNA Library Screen
The human kinase siRNA set V2.0 was purchased from QIAGEN. Each gene in
the library was represented by four different siRNA duplexes. We pooled the
four siRNAs against each gene and transfected them into the FADD-deficient
Jurkat cell line I42, which undergoes programmed necrosis exclusively in
response to TNF stimulation (Chan et al., 2003). Transfections were performed
with HiPerfect (QIAGEN) as per the manufacturer’s protocol. TNF-induced pro-
grammed necrosis (1, 10 or 100 ng/ml) was determined on day 2 and day 3 after
transfection, with propidium iodide uptake used as an indicator of cell death on
flow cytometers (BD LSRII and FACSCalibur) equipped with high throughput
sampler.
IP Kinase Assays and Western Blots
Fifty to one hundred million Jurkat cells were used for each immunoprecipita-
tion. Cell lysates were prepared by lysis in 150 mM NaCl, 20 mM Tris-Cl(pH 7.5), 0.2% NP-40, 1 mM EDTA, 3 mM NaF, 1 mM b-gylcerophosphate,
1 mM sodium orthovanadate, and 10% glycerol. After preclearing with Sephar-
ose 6B beads, complex I and complex II were immunoprecipitated with specific
antibodies for 4 hr to overnight at 4C. The resulting immune complexes were
washed with lysis buffer and resolved on 4%–12% NuPAGE gels (Invitrogen).
The rabbit anti-human RIP3 polyclonal antibody was generated by ABR Affinity
Bioreagents (Supplemental Experimental Procedures). For in vitro kinase
assays, immune complexes were incubated in kinase reaction buffer (20 mM
HEPES [pH 7.5], 2 mM DTT, 1 mM NaF, 1 mM Na3VO4, 20 mM b-glycerophos-
phate, 20 mM MgCl2, 20 mM MnCl2, 1 mM EDTA, 300 mM ATP) supplemented
with 10 mCi [32P] g-ATP and 5 mg of MBP (Stressgen) for 30 min at 30C.
Samples were resolved on 4%–12% NuPAGE gels (Invitrogen) and exposed
to autoradiographic films. Densitometry measurements were performed with
the Biorad VersaDoc MP4000 imaging station and analyzed with the Quantity
One software.
Metabolic Labeling with [32P]-Phosphate
Ten million FADD-deficient Jurkat cells were resuspended at 1 3 106 cells/ml
of phosphate-free medium and incubated for 40 min at 37C. Cells were spun
down and resuspended in phosphate-free medium containing 1 mCi of [32P]-
orthophosphate and incubated for 2 hr prior to stimulation with TNF for 2 hr. In
some experiments, 30 mM of necrostatin-1 was added to the cells 1 hr prior to
TNF stimulation. For MEFs, 3,000,000 cells per IP sample were seeded one
day before the labeling experiment. Cells were treated with TNF for 6 hr prior
to cell lysis. Immunoprecipitations were performed with RIP1- or RIP3-specific
antibody and resolved on SDS-PAGE.
Transfections of DNA Plasmids and siRNAs
For plasmid transfections, Jurkat cells were transfected with 20 mg of expres-
sion vectors using the BTX 630 Electro Cell Manipulator (262V, 725 ohms,
1050 mFd). After 16–20 hr, cells were treated with the indicated stimuli and
cell death was measured by flow cytometry using PI as an indicator of cell
death. Cell death was determined in the GFP-positive transfected populations.
Percentage cell loss was calculated with the following formula: % cell loss =
(1 [number of live cells in treated sample/number of live cells in untreated
sample]) 3 100. For 293T cells, plasmids were transfected using Fugene 6
as per the manufacturer’s protocol (Roche). For siRNA transfections, cells
were transfected with 150 nM siRNA oligonucleotides using HiPerfect
(QIAGEN) as per the manufacturer’s protocol. Transfected cells were tested
for response to TNF 48 hr after transfection. In all cell death assays, the
mean ± SEM of triplicates was presented. Statistical significance was deter-
mined with the Student’s t test.
Induction of Programmed Necrosis
To induce programmed necrosis in TNFR2+ Jurkat cells and L929 cells,
we pretreated cells with 50 mM zVAD-fmk for 1 hr prior to stimulation with
100 ng/ml rhTNFa (rmTNFa for L929 cells). Programmed necrosis was induced
in caspase-8- and FADD-deficient Jurkat cells with 100 ng/ml rhTNFa. Cell
death was determined by propidium iodide (PI) staining and flow cytometry.
In some experiments, we stained cells with Annexin V and FAM-FLICA (for
active caspases) to confirm that the cells were undergoing programmed
necrosis, but not apoptosis. For MEFs, cells were pretreated with 20 mM
zVAD-fmk and 1 mg/ml cycloheximide for 1 hr before TNF stimulation. Cell
death was determined using the CellTiter 96 AQueous Non-Radioactive Assay
(MTS assay, Promega) and in some cases by PI uptake and 1 mM 20,70-dichlor-
odihydrofluorescein diacetate (H2DCFDA) on flow cytometry. For primary
activated T cells, splenocytes from RIP3/ or wild-type littermates were
activated with 5 mg/ml Concanavalin A for 2 days, followed by another 2 days
of culture in 100 U/ml IL-2. Where applicable, cells were treated with 50 mM
zVAD-fmk or 1 mM geldanamycin for 1 hr prior to the induction of cell death.
For the induction of zVAD-induced necrosis and oxidative stress cell death,
L929 cells were transfected with siRNA and treated with different doses of
zVAD-fmk (Sigma) for 24–48 hr to induce autophagic cell death, or 0.2 mM
H2O2 for 6 hr to induce oxidative stress. Cell death was measured by MTS
assay (Promega). Procedures for cell death assays with VV-infected cultures
can be found in the Supplemental Experimental Procedures.Cell 137, 1112–1123, June 12, 2009 ª2009 Elsevier Inc. 1121
Vaccinia Virus Infections
All animal experiments were approved by the institutional animal care and use
committee. The RIP3/ mice were backcrossed to C57BL/6J background for
at least five generations. Ten-week-old mice were infected with 23 106 plaque
forming units (pfu) of Western Reserve strain of vaccinia virus via the intraper-
itoneal route. For intracellular TNF staining, PECs were harvested 24 hr after
infection, incubated with Golgi plug for 4 hr, fixed and permeabilized with
the BD IntraSureTM Kit (BD PharMingen). For quantitative PCR analyses, total
RNA from tissues were isolated 24 hr after infection and real-time PCR was
performed with iQ SYBR Green Supermix on a Biorad iCycler. For in vitro
VV infections, activated T cells and MEFs were infected with recombinant
GFP-VV at a multiplicity of infection (moi) of 10 and 0.5, respectively. Cells
were stimulated with TNF or anti-CD3 antibody 6–8 hr after infection. Cell
death was determined using PI uptake by flow cytometry. For liver extract
immunoprecipitations, liver extracts were obtained by homogenization in
0.5 M sucrose, 10 mM HEPES (pH 7.6), 25 mM KCl, 1 mM EDTA, 10% glycerol,
1 mM DTT, and 13 Complete Protease Inhibitor Cocktail (Roche) in a tissue
grinder. The homogenates were further lysed by 1:10 dilution of crude homo-
genates in lysis buffer (150 mM NaCl, 20 mM Tris-Cl [pH 7.5], 0.2% NP-40,
1 mM EDTA, 3 mM NaF, 1 mM b-gylcerophosphate, 1 mM sodium orthovana-
date, and 10% glycerol) prior to immunoprecipitations with RIP1-specific
antibody (BD PharMingen clone 38).
SUPPLEMENTAL DATA
Supplemental Data include Supplemental Experimental Procedures, nine
figures, and two tables and can be found with this article online at http://
www.cell.com/supplemental/S0092-8674(09)00642-4.
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